Clinical trial
PET Imaging With Tc-94m Sestamibi to Assess Resistance to Chemotherapy
NCT00082368 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00082368 |
|---|---|
| Title | PET Imaging With Tc-94m Sestamibi to Assess Resistance to Chemotherapy |
| Official title | A Pilot Study of Tc-94m Sestamibi PET MDR Imaging |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cancer |
| Intervention type | Drug |
| Interventions | Tariquidar, Tc-94m Sestamibi |
| Enrollment | 12 |
| Start date | May 16, 2004 |
| Primary completion | Apr 14, 2014 |
| Completion | Apr 14, 2014 |
| First posted | May 6, 2004 |
| Last update posted | Aug 17, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: